GlassScriptPhysician profile
Robert C Coppola
NPI 1780672295
$3,645.48
in general payments reported to CMS, 2019-2025
28 companies · $446 in 2025
The $446 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $510 · 2020: $162 · 2021: $181 · 2022: $210 · 2023: $1,330 · 2024: $806 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,946 · Consulting Fee: $600 · Entertainment: $35.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,946.39 |
| Consulting Fee | $600.00 |
| Entertainment | $35.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $642.55 | 2023 | Zeposia |
| Alcon Vision LLC | $579.30 | 2019-2023 | Total30, Rocklatan |
| Aerie Pharmaceuticals, INC. | $277.54 | 2019-2021 | |
| Biogen, INC. | $255.29 | 2024-2025 | Leqembi, Tysabri, Vumerity |
| Ani Pharmaceuticals, INC. | $238.67 | 2024-2025 | Purified Cortrophin Gel |
| Coopervision INC. | $201.78 | 2021-2024 | Clariti Contact Lens, Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $191.93 | 2023-2025 | Acuvue |
| Oyster Point Pharma, INC. | $150.02 | 2022-2023 | Tyrvaya |
| Bausch & Lomb Americas INC. | $139.40 | 2022-2024 | Vyzulta, Miebo |
| Catalyst Pharmaceuticals, INC. | $139.11 | 2024-2025 | |
| Regeneron Pharmaceuticals, INC. | $111.10 | 2019 | |
| Emd Serono, INC. | $110.45 | 2023 | Mavenclad |
| Johnson & Johnson Surgical Vision, INC. | $94.29 | 2024 | Tecnis Iol |
| Banner Life Sciences, LLC | $90.53 | 2021-2023 | |
| New World Medical,INC. | $84.18 | 2024 | Ahmed Glaucoma Valve, Clearpath, Streamline |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lkc Technologies, INC. | $46.93 | 2024 | |
| Sun Pharmaceutical Industries INC. | $36.55 | 2019 | |
| Optos, INC. | $35.33 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Eyevance Pharmaceuticals LLC | $29.99 | 2019 | |
| Dompe US, INC. | $25.87 | 2022 | |
| Aucta Pharmaceuticals, INC. | $25.48 | 2024-2025 | Motpoly Xr |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $24.11 | 2021 | |
| Alexion Pharmaceuticals, INC. | $24.00 | 2023 | Soliris |
| Thea Pharma INC. | $23.13 | 2024 | Iyuzeh |
| Topcon Healthcare, INC. | $22.67 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Quidel Corporation | $8.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Coppola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.